MSB 2.08% 94.0¢ mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-827

  1. 2,870 Posts.
    lightbulb Created with Sketch. 2023
    Welcome Phaedrus, hopefully you own the Moorooduc winery rather than be a reincarnation of an ancient philosopher. You see I happen to like a drink.

    Lower back pain at the moment - thought it might have been caused by extra filtration via my kidneys!

    Such diatribe and conspiracy theories abound at the moment. Explains the share price actually.

    Joining the dots was a prep school activity, murder mystery’s came along a lot later.

    For those wanting to believe in a conspiracy read Fox News , then open Cnn. It’s fun.

    There’s not a stone left unturned by the team at Meso as they go about having scientific breakthroughs approved.

    Every scenario is visited and revisited.

    The talk at the moment about Novartis’s real target being Gvhd is nonsensical.

    Ards - a cure- coming soon .

    They signed up after the second interim report, which was to continue. No futility signal.


    Share price is depressed because we are all waiting on Clbp results.


    Reg

    The bottom line is my back hurts, hope the drug works!






 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.0¢
Change
-0.020(2.08%)
Mkt cap ! $1.073B
Open High Low Value Volume
95.5¢ 97.0¢ 93.5¢ $1.424M 1.507M

Buyers (Bids)

No. Vol. Price($)
8 29390 93.5¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 14089 2
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.